# PET Imaging of Cyclooxygenase in Multiple Sclerosis

> **NCT05062083** · PHASE2 · TERMINATED · sponsor: **National Institute of Mental Health (NIMH)** · enrollment: 7 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** 11C-MC1
- **DRUG:** 11C-PS13
- **DRUG:** Ketoprofen
- **DRUG:** Celecoxib

## Key facts

- **NCT ID:** NCT05062083
- **Lead sponsor:** National Institute of Mental Health (NIMH)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-06-07
- **Primary completion:** 2023-09-05
- **Final completion:** 2024-01-30
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** due to futility
- **Last updated:** 2024-06-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05062083

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05062083, "PET Imaging of Cyclooxygenase in Multiple Sclerosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05062083. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*